openbrolly Health is one of five projects to win funding to improve cancer care in Scotland. It has won a share of £325,000 in funding from the first round of the Cancer Innovation Challenge, launched by the Scottish Government’s Chief Medical Officer Dr. Catherine Calderwood.
openbrolly Health’s project, PROEMS, is being delivered in partnership with the ALLIANCE, Robert Gordon University and Professor Angus Watson at NHS Highland. It seeks to provide a platform for collecting information from patients (PROMS/PREMS) which will in turn provide more personalised care, more opportunities for self management and more data for researchers to work with.
Peter Hall, Medical Oncologist and Senior Clinical Lecturer at the University of Edinburgh, and clinical lead for the Cancer Innovation Challenge, said:
“Being able to measure how cancer and its treatment is affecting patients from their own perspective will unlock real opportunities for patient-centred care. Insights range from an ability to monitor patient satisfaction across a whole service to enabling alerts when an individual patient reports a high risk treatment side effect, allowing early preventative management.”
Stuart Fancey, Director of Research and Innovation at the Scottish Funding Council, added:
“Combining the different areas of expertise in the three innovation centres, the NHS and industry, the Cancer Innovation Challenge is driving collaboration and helping Scotland to become a world leading carer for people with cancer. The response to this initial funding round is hugely encouraging and is good news for the future care of cancer patients throughout Scotland.”
The Cancer Innovation Challenge aims to inspire novel data and tech innovations to help Scotland become a world leader in cancer care. It is funded by the Scottish Funding Council, and delivered by three Scottish innovation centres – led by the Data Lab and supported by the Digital Health and Care Institute (DHI), and Stratified Medicine Scotland (SMS).